Pages

Wednesday, December 15, 2010

Robert Lanza Discusses Stem Cell Research Advances: “Berlin Patient” Said to be Cured of HIV

From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology
Robert Lanza has been in the forefront of stem cell research, with a breakthrough in deriving a “universal” blood supply from stem cells. In the current field of stem cell research, the blood research branch of stem cell research seems to have taken another great leap as, for the first time, a man has been reported as having been cured of HIV through stem cell therapy.

The struggle against AIDS has been considerable and has been an ongoing battle for many years, especially as the number of those infected continues to increase all over the world. That stem cells have now been conclusively proven (through extensive testing on the patient after the treatment) to have cured HIV marks a great advancement against the disease.
From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology
Robert Lanza’s universal blood research is but one part of blood-related stem cell research. The Berlin Patient, as he was dubbed, had undergone stem cell transplants, with stem cells coming from an individual with a unique genetic profile: a mutation that created CD4 cells that did not have CCR5 receptors. This type of homozygosity is present in less than 1% of Caucasians, and greatly reduces HIV risks in an individual.

Through these transplanted stem cells, the original HIV-host CD4 cells started to become overrun and consequently eclipsed by the new CD4 cells, eliminating the infection. The Berlin Patient’s success has been spreading like wildfire through the medical world and is lauded as a great achievement not only in the field, but in history, as well.

Robert Lanza’s own stem cell research advances can be found at www.robertlanza.com.

From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology

Thursday, November 18, 2010

Robert Lanza Presents the Basics of Stem Cell Research

From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology
Robert Lanza’s expansive and adorned career is rooted firmly in the fundamentals of stem cell research. His research into stem cells and their use as a potential derivative for organ and tissue cells have been lauded as medical breakthroughs. His research has allowed scientists all over the world to gain a deeper understanding of nuclear transfers and how growing organ tissues from stem cells could be more beneficial to humans.

All of this research stems from the stem cell. The stem cell is a remarkable type of cell which has the potential to grow and develop into nearly any other type of cell found in the human body. Robert Lanza specializes in stem cell research that focuses on developing these cells into other organ tissues.

Stem cells also serve as the body’s repair system in many types of tissues. It has the potential to divide and develop almost infinitely, a continuous renewal of body tissue even after the stem cell has been inactive for long periods of time. Mainly, scientists work on two types of stem cells: the embryonic stem cells and the somatic or adult stem cells. The embryonic stem cells in particular have been given particular emphasis as they have more potential in terms of developing and repairing other types of body tissues.
From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology
Early embryonic stem cells were derived from mice embryos, but recent developments, such as the one Robert Lanza has pioneered, have allowed scientists to use stem cells of human embryos. These stem cells are referred to as human embryonic stem cells. Human embryonic stem cells made use of embryos fertilized through in vitro fertilization that were no longer needed for reproductive purposes. This is done with the informed consent of the donor.

These stem cells are what makes the blastocyst (the three- to five-day old embryo) develop into a whole organism. Through stem cell research, more possibilities are being opened up to the medical field in terms of repairing human tissue and organ damage. Robert Lanza’s stem cell studies are profiled at www.robertlanza.com.



From Robert Lanza: Chief Scientific Officer of Advanced Cell Technology